All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile

Journal of Interferon and Cytokine Research

Volumn 30, Issue 6, 2010, Pages 399-406

  Bai, Aiping ^a,b   Lu, Nonghua ^a   Zeng, Hao ^a   Li, Zhengrong ^a   Zhou, Xiaodong ^a   Chen, Jiang ^a   Liu, Pi ^a   Peng, Zhikang ^b   Guo, Yuan ^a  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (7,8,9,10 TETRAHYDRO 5,7,7,10,10 PENTAMETHYL 5H BENZO[E]NAPHTHO[2,3 B][1,4]DIAZEPIN 13 YL)BENZOIC ACID; GAMMA INTERFERON; GASTROINTESTINAL AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 14; MYELOPEROXIDASE; RETINOIC ACID; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; COLITIS; COLON; CYTOKINES; DIBENZAZEPINES; GATA3 TRANSCRIPTION FACTOR; MALE; MICE; MUCOUS MEMBRANE; PEROXIDASE; RETINOIDS; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH2 CELLS; TRETINOIN; TRINITROBENZENESULFONIC ACID;

MURINAE; MUS;

EID: 77953570986     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0028     Document Type: Article

References (41)

1. Bai A, Guo Y, Lu N. 2007a. The effect of the cholinergic antiinfl ammatory pathway on experimental colitis. Scand J Immunol 66 ( 5 ): 538-545.
2. Bai A, Hu P, Chen J, Song X, Chen W, Peng W, Zeng Z, Gao X. 2007b. Blockade of STAT3 by antisense oligonucleotide in TNBSinduced murine colitis. Int J Colorectal Dis 22 ( 6 ): 625-635.
3. Bai A, Lu N, Guo Y, Chen J, Liu Z. 2009a. Modulation of infl ammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin Exp Immunol 156 ( 2 ): 353-362.
4. Bai A, Lu N, Guo Y, Fan X. 2008. Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis. Dig Dis Sci 53 ( 2 ): 421-428.
5. Bai A, Lu N, Guo Y, Liu Z, Chen J, Peng Z. 2009b. All-trans retinoic acid down-regulates infl ammatory responses by shifting the Treg/Th17 profi le in human ulcerative and murine colitis. J Leukoc Biol 86 ( 4 ): 959-969.
6. Bai AP, Ouyang Q, Hu RW. 2005. Diallyl trisulfi de inhibits tumor necrosis factor-alpha expression in infl ammed mucosa of ulcerative colitis. Dig Dis Sci 50 ( 8 ): 1426-1431.
7. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204 ( 8 ): 1737-1739.
8. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS. 1996. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for infl ammatory bowel disease. Scand J Immunol 43 ( 4 ): 456-463.
9. Cheng X, Chen Y, Xie JJ, Yao R, Yu X, Liao MY, Ding YJ, Tang TT, Liao YH, Cheng Y. 2008. Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE mice through modulation of Th1/Th2 balance. J Mol Cell Cardiol 45 ( 2 ): 168-175.
10. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Galvez J, Zarzuelo A. 2005. In vivo quercitrin anti-infl ammatory effect involves release of quercetin, which inhibits infl ammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35 ( 2 ): 584-592.
11. Dawson HD, Collins G, Pyle R, Key M, Weeraratna A, Deep-Dixit V, Nadal CN, Taub DD. 2006. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol 7, 27.
12. Dieckgraefe BK, Korzenik JR, Anant S. 2006. Growth factors as treatment options for intestinal infl ammation. Ann N Y Acad Sci 1072: 300-306.
13. Ina K, Itoh J, Fukushima K, Kusugami K, Yamaguchi T, Kyokane K, Imada A, Binion DG, Musso A, West GA, Dobrea GM, McCormick TS, Lapetina EG, Levine AD, Ottaway CA, Fiocchi C. 1999. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 163 ( 2 ): 1081-1090.
14. Iwata M, Eshima Y, Kagechika H. 2003. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15 ( 8 ): 1017-1025.
15. Kanda H, Yokota K, Kohno C, Sawada T, Sato K, Yamaguchi M, Komagata Y, Shimada K, Yamamoto K, Mimura T. 2007. Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios. Mod Rheumatol 17 ( 5 ): 364-368.
16. Kawashima M, Miossec P. 2005. Effect of treatment of rheumatoid arthritis with infl iximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic infl ammation and disease activity. Ann Rheum Dis 64 ( 3 ): 415-418.
17. Klopcic B, Appelbee A, Raye W, Lloyd F, Jooste JC, Forrest CH, Lawrance IC. 2008. Indomethacin and retinoic acid modify mouse intestinal infl ammation and fi brosis: a role for SPARC. Dig Dis Sci 53 ( 6 ): 1553-1563.
18. Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, Scholmerich J, Gross V, Falk W. 1997. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces infl ammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107 ( 2 ): 353-358.
19. Lee JS, Lee CM, Jeong YI, Jung ID, Kim BH, Seong EY, Kim JI, Choi IW, Chung HY, Park YM. 2007. d -Pinitol regulates Th1/Th2 balance via suppressing Th2 immune response in ovalbumininduced asthma. FEBS Lett 581 ( 1 ): 57-64.
20. Leng J, Yao H, Shen J, Wang K, Zhuo G, Wang Z. 2008. Co-expression of IL-18 binding protein and IL-4 regulates Th1/Th2 cytokine response in murine collagen-induced arthritis. Acta Biochim Biophys Sin (Shanghai) 40 ( 2 ): 116-124.
21. Matsuno Y, Ishii Y, Yoh K, Morishima Y, Haraguchi N, Kikuchi N, Iizuka T, Kiwamoto T, Homma S, Nomura A, Sakamoto T, Ohtsuka M, Hizawa N, Takahashi S. 2007. Overexpression of GATA-3 protects against the development of hypersensitivity pneumonitis. Am J Respir Crit Care Med 176 ( 10 ): 1015-1025.
22. Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, Kishi Y, Sakuraba A, Hitotsumatsu O, Ogata H, Koganei K, Fukushima T, Kanai T, Watanabe M, Ishii H, Hibi T. 2004. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut 53 ( 9 ): 1303-1308.
23. Meijer MJ, Mieremet-Ooms MA, van Duijn W, van der Zon AM, Hanemaaijer R, Verheijen JH, van Hogezand RA, Lamers CB, Verspaget HW. 2007. Effect of the anti-tumor necrosis factoralpha antibody infl iximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in infl ammatory bowel disease. Infl amm Bowel Dis 13 ( 2 ): 200-210.
24. Miyagawa N, Homma T, Kagechika H, Shudo K, Nagai H. 2003. Effect of synthetic retinoid, TAC-101, on experimental autoimmune disease. Pharmacology 67 ( 1 ): 21-31.
25. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, Pallone F. 1997. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112 ( 4 ): 1169-1178.
26. Mosmann TR, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 ( 3 ): 138-146.
27. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 ( 5835 ): 256-260.
28. Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR, Bhan A, Autschbach F, Sullivan BM, Szabo SJ, Glimcher LH, Blumberg RS. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195 ( 9 ): 1129-1143.
29. Niessner M, Volk BA. 1995. Altered Th1/Th2 cytokine profi les in the intestinal mucosa of patients with infl ammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101 ( 3 ): 428-435.
30. Nozaki Y, Tamaki C, Yamagata T, Sugiyama M, Ikoma S, Kinoshita K, Funauchi M. 2006. All-trans-retinoic acid suppresses interferongamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis. Rheumatol Int 26 ( 9 ): 810-817.
31. Oliva-Hemker M, Fiocchi C. 2002. Etiopathogenesis of infl ammatory bowel disease: the importance of the pediatric perspective. Infl amm Bowel Dis 8 ( 2 ): 112-128.
32. Peng SL. 2006. The T-box transcription factor T-bet in immunity and autoimmunity. Cell Mol Immunol 3 ( 2 ): 87-95.
33. Podolsky DK. 2002. Infl ammatory bowel disease. N Engl J Med 347, 417.
34. Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE. 1995. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154 ( 1 ): 450-458.
35. Ray A, Cohn L. 1999. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway infl ammation. J Clin Invest 104 ( 8 ): 985-993.
36. Reifen R, Nur T, Ghebermeskel K, Zaiger G, Urizky R, Pines M. 2002. Vitamin A defi ciency exacerbates infl ammation in a rat model of colitis through activation of nuclear factor-kappaB and collagen formation. J Nutr 132 ( 9 ): 2743-2747.
37. Shen C, de Hertogh G, Bullens DM, Van Assche G, Geboes K, Rutgeerts P, Ceuppens JL. 2007. Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Infl amm Bowel Dis 13 ( 3 ): 308-316.
38. Varilek GW, Yang F, Lee EY, deVilliers WJ, Zhong J, Oz HS, Westberry KF, McClain CJ. 2001. Green tea polyphenol extract attenuates infl ammation in interleukin-2-defi cient mice, a model of autoimmunity. J Nutr 131 ( 7 ): 2034-2039.
39. Weaver A, Goncalves da Silva A, Nuttall RK, Edwards DR, Shapiro SD, Rivest S, Yong VW. 2005. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J 19 ( 12 ): 1668-1670.
40. Zanin-Zhorov A, Bruck R, Tal G, Oren S, Aeed H, Hershkoviz R, Cohen IR, Lider O. 2005. Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J Immunol 174 ( 6 ): 3227-3236.
41. Zunino SJ, Storms DH, Stephensen CB. 2007. Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr 137 ( 5 ): 1216-1221.